Abstract
Pulmonary hypertension represents a significant risk factor for peri-operative death in patients undergoing cardiac transplantation. Heart-lung transplantation is generally the only procedure available for patients whose pulmonary hypertension can not be reversed by conventional pharmacologic means. We present a pediatric patient with end-stage cardiac disease and refractory pulmonary hypertension who was treated with long-term intravenous prostacyclin. This resulted in a significant enough improvement in her hemodynamics to allow for successful cardiac transplantation alone.
Original language | English |
---|---|
Pages (from-to) | 785-788 |
Number of pages | 4 |
Journal | Journal of Heart and Lung Transplantation |
Volume | 20 |
Issue number | 7 |
DOIs | |
State | Published - 2001 |